The phase 1b, 16-week, multiple-dose ascending trial (NCT05613387) showed a mean body weight reduction of 4.8%, 8.6% and 8.3% at OW doses of up to 2.4 mg, 4.8 mg and 9.0 mg, respectively [116]
370,371 Alignment between the circadian clock and environmental and physiologic cyclesor circadian synchronycan be disturbed by a range of common behaviors and conditions, including shiftwork, late-night social or other activities, and travel through time zones
Recurrent, which presents with episodes that occur more frequently, at intervals under 6 months
Unlike many peptides that require protective carriers or rapid delivery to avoid degradation, BPC-157 maintains its structural integrity long enough to exert therapeutic effects